Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryoko Umebayashi

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Aging|December 8, 2018
Abdominal aortic aneurysm in aged populationRyoko Umebayashi, Haruhito A Uchida, Jun Wada
Acta Medica Okayama|December 25, 2019
The Aging Population and Research into Treatments for Abdominal Aortic AneurysmsRyoko Umebayashi, Haruhito Adam Uchida, Jun Wada
International Journal of Molecular Sciences|August 26, 2022
Cilostazol Attenuates AngII-Induced Cardiac Fibrosis in apoE Deficient MiceYoshiko Hada, Haruhito A Uchida, Ryoko Umebayashi, et al.
Journal of Personalized Medicine|January 21, 2022
Prevalence of Chronic Kidney Disease and Variation of Its Risk Factors by the Regions in Okayama PrefectureRyoko Umebayashi, Haruhito Adam Uchida, Natsumi Matsuoka-Uchiyama, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 14, 2018
Cilostazol Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysms but Not Atherosclerosis in Apolipoprotein E-Deficient MiceRyoko Umebayashi, Haruhito A Uchida, Yuki Kakio, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|November 17, 2018
The clinical efficacy of angiotensin II type1 receptor blockers on inflammatory markers in patients with hypertension: a multicenter randomized-controlled trial; MUSCAT-3 studyRyoko Umebayashi, Haruhito A Uchida, Yuka Okuyama, et al.
Blood Pressure Monitoring|January 13, 2017
Practical efficacy of olmesartan versus azilsartan in patients with hypertension: a multicenter randomized-controlled trial (MUSCAT-4 study)Yuki Kakio, Haruhito A Uchida, Ryoko Umebayashi, et al.
Diseases (Basel, Switzerland)|November 26, 2024
The Change in Public Perception and Knowledge Acquisition Methods of Chronic Kidney Disease Among General Population in Okayama Prefecture, JapanRyoko Umebayashi, Natsumi Matsuoka-Uchiyama, Hitoshi Sugiyama, et al.
Internal Medicine (Tokyo, Japan)|January 7, 2014
Large vessel vasculitis with myelodysplastic syndromeTakayuki Katsuyama, Haruhito Adam Uchida, Kishio Toma, et al.
Biomolecules|August 26, 2022
Edaravone Attenuated Angiotensin II-Induced Atherosclerosis and Abdominal Aortic Aneurysms in Apolipoprotein E-Deficient MiceHaruhito A Uchida, Tetsuharu Takatsuka, Yoshiko Hada, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Aging|December 8, 2018
Abdominal aortic aneurysm in aged populationRyoko Umebayashi, Haruhito A Uchida, Jun Wada
Acta Medica Okayama|December 25, 2019
The Aging Population and Research into Treatments for Abdominal Aortic AneurysmsRyoko Umebayashi, Haruhito Adam Uchida, Jun Wada
International Journal of Molecular Sciences|August 26, 2022
Cilostazol Attenuates AngII-Induced Cardiac Fibrosis in apoE Deficient MiceYoshiko Hada, Haruhito A Uchida, Ryoko Umebayashi, et al.
Journal of Personalized Medicine|January 21, 2022
Prevalence of Chronic Kidney Disease and Variation of Its Risk Factors by the Regions in Okayama PrefectureRyoko Umebayashi, Haruhito Adam Uchida, Natsumi Matsuoka-Uchiyama, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 14, 2018
Cilostazol Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysms but Not Atherosclerosis in Apolipoprotein E-Deficient MiceRyoko Umebayashi, Haruhito A Uchida, Yuki Kakio, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|November 17, 2018
The clinical efficacy of angiotensin II type1 receptor blockers on inflammatory markers in patients with hypertension: a multicenter randomized-controlled trial; MUSCAT-3 studyRyoko Umebayashi, Haruhito A Uchida, Yuka Okuyama, et al.
Blood Pressure Monitoring|January 13, 2017
Practical efficacy of olmesartan versus azilsartan in patients with hypertension: a multicenter randomized-controlled trial (MUSCAT-4 study)Yuki Kakio, Haruhito A Uchida, Ryoko Umebayashi, et al.
Diseases (Basel, Switzerland)|November 26, 2024
The Change in Public Perception and Knowledge Acquisition Methods of Chronic Kidney Disease Among General Population in Okayama Prefecture, JapanRyoko Umebayashi, Natsumi Matsuoka-Uchiyama, Hitoshi Sugiyama, et al.
Internal Medicine (Tokyo, Japan)|January 7, 2014
Large vessel vasculitis with myelodysplastic syndromeTakayuki Katsuyama, Haruhito Adam Uchida, Kishio Toma, et al.
Biomolecules|August 26, 2022
Edaravone Attenuated Angiotensin II-Induced Atherosclerosis and Abdominal Aortic Aneurysms in Apolipoprotein E-Deficient MiceHaruhito A Uchida, Tetsuharu Takatsuka, Yoshiko Hada, et al.
Pageof 3